MONJUVI
Live / Registered — Registered (as of 14 Apr 2020)
What this means for you
Registered since 14 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88074194
- Registration number
- 6031814
- Mark type
- Stylized text
- Filed
- 10 Aug 2018
- Published for opposition
- 16 Jul 2019
- Registered
- 14 Apr 2020
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Owner
- INCYTE HOLDINGS CORPORATION, WILMINGTON, DE, US
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
Prosecution history
- 14 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Apr 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 07 Mar 2020 — TTAB RELEASE CASE TO TRADEMARKS
- 07 Mar 2020 — OPPOSITION TERMINATED NO. 999999
- 07 Mar 2020 — OPPOSITION DISMISSED NO. 999999
- 13 Jan 2020 — OPPOSITION INSTITUTED NO. 999999
- 20 Nov 2019 — POST PUBLICATION AMENDMENT - ENTERED
- 18 Nov 2019 — ASSIGNED TO PETITION STAFF